The Procter & Gamble Company

The Procter & Gamble Company’s most recent 10-Q, filed January 23, 2026, offers a financial update for the six months ended December 31, 2025. Net sales for this period reached $44,594 million, an increase from $43,619 million in the prior year. This top-line expansion, however, was accompanied by a decrease in operating income, which fell to $11,222 million from $11,538 million over the same six-month period. A closer look at the components reveals that cost of products sold increased to $21,721 million in 2025 from $20,839 million in 2024, while selling, general and administrative expense rose to $11,651 million from $11,242 million. The MD&A outlines its purpose to provide an understanding of Procter & Gamble’s financial condition by focusing on changes in key measures, suggesting these cost trends would be a focal point for management’s explanation.

The forensic accounting metrics typically employed for a deeper dive are not available for this filing. Beneish’s M-Score (1999), an eight-ratio earnings-manipulation detector, is not provided. Similarly, Altman’s Z″ (1968), a bankruptcy-distress index, is unavailable, preventing an assessment of the company’s financial stability from that perspective. Piotroski’s F-Score (2000), a 9-point fundamental strength scan, is also absent, which would otherwise offer insight into profitability, leverage, and operating efficiency. Finally, the Fog Index (1964), a readability score where 12 equals a newspaper and 18+ suggests obfuscation, is not calculated for this document. Consequently, the filing offers no quantitative signals from these established models.

Item 7 of the 10-Q details the structure and intent of the Management’s Discussion and Analysis. It explicitly states that the MD&A is provided as a supplement and should be read in conjunction with our Consolidated Financial Statements and accompanying Notes. The MD&A is organized into specific sections, including “Overview,” “Recent Developments,” “Summary of Results – Six Months Ended December 31, 2025,” “Economic Conditions and Uncertainties,” and “Liquidity and Capital Resources.” This detailed structure signals management’s intent to guide the reader through specific areas of performance and risk, emphasizing “changes in certain key measures from year to year.” Such an organization is designed to provide context for the reported financial figures, like the observed shifts in net sales and operating income.

This filing, while providing core financial statements, offers limited scope for a complete forensic analysis due to the unavailability of key quantitative scores. Without Beneish’s M-Score, Altman’s Z″, Piotroski’s F-Score, or the Fog Index, the reader lacks immediate, academically-grounded signals regarding potential earnings manipulation, financial distress, fundamental strength, or document readability. The observed increase in net sales alongside a decrease in operating income warrants further investigation into the full MD&A and notes to the financial statements, which are not provided in these excerpts. Therefore, while the filing presents a factual account of recent financial performance, it does not, in this truncated form, provide sufficient data to form a comprehensive view on whether the security is mispriced or to assess the full implications of the reported financial movements.